The addition of liguid fructose to a Western-type diet in LDL-R-/- mice induces liver inflammation and fibrogenesis markers without disrupting insulin receptor signalling after an insulin challenge

dc.contributor.authorSangüesa Puigventós, Gemma
dc.contributor.authorBaena Muñoz, Miguel
dc.contributor.authorHutter, Natalia
dc.contributor.authorMontañés, José Carlos
dc.contributor.authorSánchez, Rosa María
dc.contributor.authorRoglans i Ribas, Núria
dc.contributor.authorLaguna Egea, Juan Carlos
dc.contributor.authorAlegret i Jordà, Marta
dc.date.accessioned2018-03-16T11:04:11Z
dc.date.available2018-03-16T11:04:11Z
dc.date.issued2017-03-15
dc.date.updated2018-03-16T11:04:11Z
dc.description.abstractA high consumption of fat and simple sugars, especially fructose, has been related to the development of insulin resistance, but the mechanisms involved in the effects of these nutrients are not fully understood. This study investigates the effects of a Western-type diet and liquid fructose supplementation, alone and combined, on insulin signalling and inflammation in low-density lipoprotein (LDL) receptor-deficient mice (LDL-R−/−). LDL-R−/− mice were fed chow or Western diet ±15% fructose solution for 12 weeks. Plasma glucose and insulin, and the expression of genes related to inflammation in the liver and visceral white adipose tissue (vWAT), were analysed. V-akt murine thymoma viral oncogene homolog-2 (Akt) activation was measured in the liver of the mice after a single injection of saline or insulin. None of the dietary interventions caused inflammation in vWAT, whereas the Western diet induced hepatic inflammation, which was further enhanced by liquid fructose, leading also to a significant increase in fibrogenesis markers. However, there was no change in plasma glucose or insulin, or insulin-induced Akt phosphorylation. In conclusion, hepatic inflammation and fibrogenesis markers induced by a Western diet supplemented with liquid fructose in LDL-R−/− mice are not associated with a significant impairment of hepatic insulin signalling.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec671253
dc.identifier.issn2072-6643
dc.identifier.pmid28294959
dc.identifier.urihttps://hdl.handle.net/2445/120824
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/nu9030278
dc.relation.ispartofNutrients, 2017, vol. 9, num. 278
dc.relation.urihttps://doi.org/10.3390/nu9030278
dc.rightscc-by (c) Sangüesa, Gemma et al., 2017
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)
dc.subject.classificationMetabolisme
dc.subject.classificationTeixit adipós
dc.subject.classificationSucre en l'organisme
dc.subject.otherMetabolism
dc.subject.otherAdipose tissues
dc.subject.otherSugar in the body
dc.titleThe addition of liguid fructose to a Western-type diet in LDL-R-/- mice induces liver inflammation and fibrogenesis markers without disrupting insulin receptor signalling after an insulin challenge
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
671253.pdf
Mida:
2.83 MB
Format:
Adobe Portable Document Format